Trial
NCT05618613
Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Context Therapeutics Inc.
Collaborators
—
Condition
Breast Cancer
Intervention
Elacestrant
Why stopped
Sponsor decision to discontinue onapristone development.
Provenance
Dataset: 2026-07-24 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-21